WIP1 deficiency inhibits HTLV-1 Tax oncogenesis: novel therapeutic prospects for treatment of ATL?

N. Gillet, A. Carpentier, P.-Y. Barez, L. Willems

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'WIP1 deficiency inhibits HTLV-1 Tax oncogenesis: novel therapeutic prospects for treatment of ATL?'. Together they form a unique fingerprint.

Immunology and Microbiology